Stifel Trust’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$36K Sell
240
-45
-16% -$6.95K 0.01% 298
2014
Q2
$48K Sell
285
-200
-41% -$35.6K 0.01% 276
2014
Q1
$97K Hold
485
0.02% 219
2013
Q4
$93K Hold
485
0.02% 216
2013
Q3
$83K Hold
485
0.02% 220
2013
Q2
$74K Buy
+485
New +$68.7K 0.02% 231

Other funds holding CLB

Stifel Trust's CLB Position: Q3 2014 in Review

Stifel Trust reduced its Core Laboratories (CLB) stake by 16% in Q3 2014, selling an estimated $6.95K and leaving 240 shares worth $36K. The position accounts for 0.01% of the portfolio, ranked #298.

Stifel Trust first reported a position in CLB in Q2 2013 and has held it in 6 quarters since. The position peaked at $97K in Q1 2014. 344 funds tracked by Wall St. Rank hold CLB as of Q3 2014.

  • Stifel Trust held 240 shares of Core Laboratories worth $36K as of Q3 2014.
  • Stifel Trust sold 45 Core Laboratories shares in Q3 2014, an estimated $6.95K.
  • Core Laboratories made up 0.01% of Stifel Trust's portfolio in Q3 2014, its #298 holding.
  • Stifel Trust first reported a position in Core Laboratories in Q2 2013 and has held it in 6 quarters since.
  • Stifel Trust's Core Laboratories position peaked at $97K in Q1 2014.
  • 344 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.